Swiss drugmaker Novartis to spin off generics unit Sandoz

The Basel-based company, which makes a vast array of drugs including cancer treatment Gleevec and Diovan for hypertension, says it wants to focus on its core innovation business that is built around therapeutics and technology such as gene and cell therapy.

from News-Economic Times https://ift.tt/YnU7y2P
via IFTTT

Comments

Popular posts from this blog

Zach Bryan ‘With Heaven On Tour’: Country singer to embark on international tour across Europe and North America in 2026; check tour dates and venues as presale registration begins soon

Uncle Sam vs Dragon: US, China trade barbs over role in Bangladesh ahead of elections

Peace clause invoked 6th time to offer rice subsidies